SCHEMBL10140548

SCHEMBL10140548

C=C(C)N[C@@H](CC(=O)CC)Cc1ccccc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
KMT2A Q03164 2/20 0.37
RIPK1 Q13546 1/20 0.37
TAS1R3 Q7RTX0 1/20 0.36
TAS1R1 Q7RTX1 1/20 0.36
CTSS P25774 1/20 0.36
CTSK P43235 1/20 0.36
CYP3A4 P08684 3/20 0.35
CYP2C19 P33261 1/20 0.35
MAOB P27338 1/20 0.35
CYP2D6 P10635 2/20 0.34
SLC6A2 P23975 2/20 0.34
SLC6A4 P31645 2/20 0.34
SLC6A3 Q01959 2/20 0.34
KCNH2 Q12809 1/20 0.34
PPARG P37231 1/20 0.34
PPARA Q07869 1/20 0.34
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12979945 0.88 ALDH1A1 (0.40) ALDH1A1KMT2ARIPK1TAS1R3TAS1R1
SCHEMBL12824373 0.85 ALDH1A1 (0.41) ALDH1A1KMT2ARIPK1CTSSCTSK
SCHEMBL8917906 0.84 CTSS (0.41) ALDH1A1KMT2ARIPK1TAS1R3TAS1R1
SCHEMBL8290320 0.76 CTSS (0.41) ALDH1A1KMT2ACTSSCTSKMAOB
SCHEMBL890178 0.73 CTSS (0.42) ALDH1A1KMT2ACTSSCTSKCYP3A4
SCHEMBL19544601 0.72 RIPK1 (0.40) ALDH1A1RIPK1TAS1R3TAS1R1CTSS
SCHEMBL14034476 0.72 MME (0.48) ALDH1A1KMT2ACTSSCTSKPPARG
SCHEMBL19544604 0.72 TAAR1 (0.41) ALDH1A1RIPK1CYP3A4MAOBCYP2D6
SCHEMBL755370 0.70 CTSS (0.45) ALDH1A1KMT2ACTSSCTSKCYP3A4
SCHEMBL18526772 0.70 CTSS (0.45) ALDH1A1KMT2ACTSSCTSKCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012021704-A1 HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2012-02-16 WO disclosed
WO-2011127350-A1 HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2011-10-13 WO disclosed
WO-2011081918-A1 HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC (US) 2011-07-07 WO disclosed
WO-2011031904-A1 HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC (US) 2011-03-17 WO disclosed
WO-2011031934-A1 HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2011-03-17 WO disclosed
WO-2010099527-A1 HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2010-09-02 WO disclosed
WO-2010096462-A1 LINKED DIIMIDAZOLE DERIVATIVES ENANTA PHARMACEUTICALS, INC (US) 2010-08-26 WO disclosed
WO-2010091413-A1 LINKED DIBENZIMIDAZOLE DERIVATIVES ENANTA PHARMACEUTICALS, INC. (US) 2010-08-12 WO disclosed